A Relative Bioavailability Study of LY3209590 in Healthy Participants
Clinical trial NCT05615532 · COMPLETED
Trial details
- NCT number
- NCT05615532
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-11
- Primary completion
- 2023-06-28
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.